Repros Therapeutics
RPRX
RPRX was delisted on the 31st of January, 2018.
81 hedge funds and large institutions have $414M invested in Repros Therapeutics in 2013 Q2 according to their latest regulatory filings, with 81 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
97.69% more ownership
Funds ownership: 0% → 97.69% (+98%)
23% less call options, than puts
Call options by funds: $35.1M | Put options by funds: $45.3M
Top Buyers
Top Sellers
RPRX Hedge Fund Activity: Q2 2013 in Review
81 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics (RPRX) for Q2 2013, worth a combined $414M.
Buyers outnumbered sellers: 81 funds opened new RPRX positions and 0 closed out — a net gain of 81 holders — while 0 added to existing stakes and 0 trimmed.
- 81 institutional investors held Repros Therapeutics (RPRX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $414M of Repros Therapeutics stock for Q2 2013.
- 81 funds opened new Repros Therapeutics positions in Q2 2013 and 0 closed out, a net change of +81 holders.
Based on aggregated 13F filings for Q2 2013.